Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

In the latest study, researchers found the main genetic mutations in renal cell cancer, possibly by using artificial intelligence (AI). The scientists injected mRNA vaccine made against proteins ...

Doctors at Dana-Farber say this personalized vaccine can be given after surgery to remove a tumor and train the body’s immune ...

Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell carcinoma ...